Guolan Lu is an Assistant Professor in the Department of Urology at Stanford University School of Medicine. She is a biomedical engineer cross-trained in machine learning, biomedical imaging, and spatial omics in the context of cancer biology, immunology, and pharmacology. She completed her postdoctoral training in the laboratories of Dr. Garry Nolan, PhD and Dr. Eben Rosenthal, MD, at Stanford University, where she designed and led a first-in-human clinical study for fluorescence-guided surgery in pancreatic cancer, and pioneered a single-cell spatial pharmacology approach to decode drug-target-microenvironment interactions in situ in clinical tumors.
She received her Ph.D. from the joint Biomedical Engineering Department of Georgia Tech and Emory University (advisor: Dr. Baowei Fei, PhD), where she received interdisciplinary training in medical imaging, machine learning, and digital pathology. Guolan has received multiple awards for her work, including a K99/R00 Pathway to Independence Award from the National Cancer Institute, a Young Investigator Award from The Society for Immunotherapy of Cancer (SITC), and recognition as a Rising Star in Biomedical Engineering and Science (MIT), etc. She was a fellow of the Stanford Molecular Imaging Scholars (SMIS) Program and a Stanford Translational Medicine (TRAM) Scholar.